<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Intracranial atherosclerotic disease (ICAD) is being seen as an increasingly important cause of <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Attention on this disease entity has been focused as a result of two recent events: the publication of the WASID trial and the recent Food and Drug Administration approval of the Wingspan-Gateway stent system </plain></SENT>
<SENT sid="2" pm="."><plain>This manuscript will review the evolution of the role of endovascular therapy in the management of ICAD </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, the available devices currently available for endovascular therapy will be reviewed with an eye toward peri-procedural and follow-up complication rates </plain></SENT>
</text></document>